Oxycodone Completed Phase 3 Trials for Osteoarthritis, Hip / Pain / Knee Osteoarthritis (Knee OA) / Back Pain Lower Back Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00486811A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
NCT02732262Optimal Dose of i.v Oxycodone for Postoperative Pain
NCT00412100Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation
NCT00412152Oxycodone-naloxone in Relieving Opioid-related Constipation
NCT00654069Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After Bunionectomy
NCT01192295Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
NCT01369615Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
NCT01205126An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain
NCT01167127Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT01167699Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT01165281A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
NCT01559701Long-term Safety of PF-00345439 (Oxycodone)
NCT02401750A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery
NCT00261495A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.
NCT00361504A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain
NCT00421928Tapentadol (CG5503)
NCT00449176A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
NCT01427270Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
NCT01427283A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
NCT01358526Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
NCT00399048An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)